drugset / Trial / NCT00055419
A Study of Cetuximab in Patients Who Have Stage IV Colorectal Cancer
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this clinical research study is to learn about the safety of cetuximab in patients with stage IV colorectal cancer, and who may benefit from cetuximab.
Timeline
- Start
- 2003-02
- Primary completion
- 2004-07
- Completion
- 2004-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab | Monoclonal antibody | 250 mg/m2 | — |